Your browser doesn't support javascript.
loading
Human umbilical cord mesenchymal stem cells for psoriasis: a phase 1/2a, single-arm study.
Cheng, Lamei; Wang, Siqi; Peng, Cong; Zou, Xiao; Yang, Chao; Mei, Hua; Li, Chuang; Su, Xian; Xiao, Na; Ouyang, Qi; Zhang, Mi; Wang, Qiaolin; Luo, Yan; Shen, Minxue; Qin, Qun; Wang, Honglin; Zhu, Wu; Lu, Guangxiu; Lin, Ge; Kuang, Yehong; Chen, Xiang.
Afiliación
  • Cheng L; Institute of Reproductive and Stem Cell Engineering, School of Basic Medical Science, Central South University, Changsha, 410031, China.
  • Wang S; National Engineering Research Center of Human Stem Cell, Changsha, 410205, China.
  • Peng C; National Engineering Research Center of Human Stem Cell, Changsha, 410205, China.
  • Zou X; The Department of Dermatology, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Yang C; Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, National Clinical Research Center for Geriatric Disorders (Xiangya Hospital), Changsha, 410008, China.
  • Mei H; National Engineering Research Center of Human Stem Cell, Changsha, 410205, China.
  • Li C; National Engineering Research Center of Human Stem Cell, Changsha, 410205, China.
  • Su X; National Engineering Research Center of Human Stem Cell, Changsha, 410205, China.
  • Xiao N; National Engineering Research Center of Human Stem Cell, Changsha, 410205, China.
  • Ouyang Q; National Engineering Research Center of Human Stem Cell, Changsha, 410205, China.
  • Zhang M; Institute of Reproductive and Stem Cell Engineering, School of Basic Medical Science, Central South University, Changsha, 410031, China.
  • Wang Q; National Engineering Research Center of Human Stem Cell, Changsha, 410205, China.
  • Luo Y; Institute of Reproductive and Stem Cell Engineering, School of Basic Medical Science, Central South University, Changsha, 410031, China.
  • Shen M; National Engineering Research Center of Human Stem Cell, Changsha, 410205, China.
  • Qin Q; The Department of Dermatology, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Wang H; Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, National Clinical Research Center for Geriatric Disorders (Xiangya Hospital), Changsha, 410008, China.
  • Zhu W; The Department of Dermatology, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Lu G; Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, National Clinical Research Center for Geriatric Disorders (Xiangya Hospital), Changsha, 410008, China.
  • Lin G; The Department of Dermatology, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Kuang Y; Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, National Clinical Research Center for Geriatric Disorders (Xiangya Hospital), Changsha, 410008, China.
  • Chen X; The Department of Dermatology, Xiangya Hospital, Central South University, Changsha, 410008, China.
Signal Transduct Target Ther ; 7(1): 263, 2022 08 05.
Article en En | MEDLINE | ID: mdl-35927231
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Células Madre Mesenquimatosas Tipo de estudio: Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Signal Transduct Target Ther Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Células Madre Mesenquimatosas Tipo de estudio: Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Signal Transduct Target Ther Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido